Masimo Corp
F:3M4
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Masimo Corp
F:3M4
|
US |
|
S
|
Shanghai Pharmaceuticals Holding Co Ltd
HKEX:2607
|
CN |
|
F
|
Freeport-McMoRan Inc
LSE:0R2O
|
US |
|
T
|
Travelers Companies Inc
SWB:PA9
|
US |
|
Kuaishou Technology
HKEX:1024
|
CN |
|
Fastenal Co
NASDAQ:FAST
|
US |
|
A
|
AltaGas Ltd
SWB:AQ3
|
CA |
Masimo Corp
Masimo makes patient-monitoring equipment used by hospitals and other care settings. Its best-known products measure things like blood oxygen, pulse rate, and other vital signs through sensors and monitors that help clinicians track patients during surgery, in intensive care, and in general hospital care. The company also sells some consumer health devices and related accessories. It makes money mainly by selling monitoring systems, disposable sensor cables, and other recurring-use parts that work with its devices. Hospitals and healthcare providers are the main customers, along with distributors and some consumers for its home-use products. This gives Masimo a mix of upfront equipment sales and repeat sales of consumables. What makes Masimo different is that it sits in a key spot inside the hospital monitoring chain: its technology is built into devices that doctors and nurses rely on for continuous readings. That makes the business less like a one-time equipment seller and more like a long-term supplier tied to the daily use of its own sensors and monitors.
Masimo makes patient-monitoring equipment used by hospitals and other care settings. Its best-known products measure things like blood oxygen, pulse rate, and other vital signs through sensors and monitors that help clinicians track patients during surgery, in intensive care, and in general hospital care. The company also sells some consumer health devices and related accessories.
It makes money mainly by selling monitoring systems, disposable sensor cables, and other recurring-use parts that work with its devices. Hospitals and healthcare providers are the main customers, along with distributors and some consumers for its home-use products. This gives Masimo a mix of upfront equipment sales and repeat sales of consumables.
What makes Masimo different is that it sits in a key spot inside the hospital monitoring chain: its technology is built into devices that doctors and nurses rely on for continuous readings. That makes the business less like a one-time equipment seller and more like a long-term supplier tied to the daily use of its own sensors and monitors.
Revenue Growth: Masimo delivered 8% revenue growth in Q3, with healthcare revenue reaching $371 million.
EPS & Margins: EPS rose 38% year-over-year to $1.32, and operating margin improved to 27.1%, up 450 basis points.
Guidance Update: Full-year revenue guidance was tightened to $1.51–$1.53 billion, while operating margin and EPS guidance were both raised.
Strong Demand: The company reported robust demand, highlighted by record incremental contract value of $124 million and 8% more technology boards shipped.
Capital Allocation: Masimo returned $350 million to shareholders via stock repurchases and used proceeds from a divestiture to pay down debt.
AI & Innovation: Continued investment in intelligent monitoring, wearables, and AI-enabled sensors, with key product launches and studies underway.
Commercial Execution: Ongoing realignment of sales force and enhancements in advanced monitoring are beginning to show positive results.
